Avalo Therapeutics (AVTX) Revenue (2016 - 2025)
Avalo Therapeutics (AVTX) reported Revenue of $59000.0 for Q4 2025, down 69.27% on a YoY basis from $192000.0 in Q4 2024, and down 69.27% quarter-over-quarter from $192000.0 in Q4 2024.
Avalo Therapeutics (AVTX) Revenue (2016 - 2025) Analysis & Trends
Avalo Therapeutics has reported Revenue for 10 years, with the latest figure at $59000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue fell 69.27% year-over-year to $59000.0; the trailing twelve-month figure through Dec 2025 stood at $500000.0 (up 13.38% YoY), and the FY2025 full-year result was $59000.0, down 86.62% from the prior year.
- Revenue for Q4 2025 stood at $59000.0, down from $192000.0 in the prior quarter.
- The five-year high for Revenue was $14.9 million in Q3 2022, with the low at $59000.0 in Q4 2025.
- Historically, Revenue has averaged $1.7 million across 5 years, with a median of $571000.0 in 2023.
- Annual changes were most pronounced in 2022 — Revenue surged 1007.33% — and 2023, when it sank 98.42%.
- Avalo Therapeutics' Revenue stood at $219000.0 in 2021, then surged by 309.13% to $896000.0 in 2022, then plunged by 36.27% to $571000.0 in 2023, then slumped by 66.37% to $192000.0 in 2024, then tumbled by 69.27% to $59000.0 in 2025.
- The last three Revenue figures came in at $59000.0 (Q4 2025), $192000.0 (Q4 2024), and $249000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 643,000.00 |
| Mar 31, 2023 | 475,000.00 |
| Dec 31, 2022 | 896,000.00 |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 473,000.00 |
| Dec 31, 2020 | 1.50 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 580,808.00 |